Skip to main content
logo
Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.558
+0.068 (4.56%)
Oct 19, 2026, 1:29 PM EDT - Market open

Regentis Biomaterials Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1135----
Market Cap Growth
------
Enterprise Value
278----
Last Close Price
1.496.74----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.367.36----
P/TBV Ratio
1.347.36----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.25-0.82-0.70-0.80-0.94
Net Debt / Equity Ratio
-1.16-1.30-0.78-0.67-0.65-0.51
Quick Ratio
5.422.650.050.110.141.02
Current Ratio
5.622.650.070.120.191.14
Return on Assets (ROA)
-113.59%-107.53%138.36%-116.21%-36.40%-18.55%
Return on Capital Employed (ROCE)
-116.00%-146.90%-15.50%69.50%19.10%-170.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-157.00%-39.10%----
Buyback Yield / Dilution
-2034.86%-249.41%6.52%-6.97%--
SEC Filings: 10-K · 10-Q